That is essential, because the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work. To put it simply, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (tech predictions). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're created to do. This was a breakthrough practically nobody discovered. But it's going to have profound implications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of financial investment opportunities in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (artificial intelligence). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it pulled back maybe significantly prior to going greater - melania trump. I have actually been covering bitcoin for a long period of time now. One of the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily informing readers. However that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. exponential growth. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are many great private companies on the brink of striking the public markets And I've been working on a brand-new method for you to invest even prior to these business go public.
This chance has been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area for free.
Emma Walsh here, handling editor of the Journal. Regular Diary readers understand that tech isn't our normal beat (jeff brown investor prediction). And when it comes to tech investing, we leave it to the specialists. The good news is, we have a number of such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (united arab emirates). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and a lot more. These patterns are experiencing exponential growth and developing incredible chances for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. angel investor. But despite what many readers might believe, this is a pattern that's simply getting going. Despite the fact that the COVID-19 pandemic disrupted supply chains last year, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown investment prediction). Losing two months of production and sales actually impacts the number of 5G devices are sold in the fiscal year. When you think about all of that, offering 250 million units is exceptional. More significantly, the delays triggered by the pandemic developed a lots of suppressed need. Which need is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - angel investor. Which's not my only 5G prediction When I've discussed 5G in the past, I've described its 3 different phases.
In Phase Two, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Stage Three, 5G services start to be used (jeff brown 1 biotech company). That's when we begin to see applications operating on 5G networks. Believe of things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage Three by this summer season. This starts something of a virtuous cycle: Many people do not truly care about the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open a suite of amazing applications: self-driving cars, the Internet of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment opportunities going forward will be huge. Stepping far from 5G, the next essential innovation I anticipate in 2021 is CRISPR genetic editing. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And during that time, there were really only three companies running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This whole market is successfully a greenfield chance.
There's space for many companies to exist in this space. future report. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can properly predict the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential due to the fact that the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error procedure. And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug therapies produced using this technology. This was among those breakthroughs that practically nobody discovered. But it's going to have extensive implications for curing illness. And, obviously, there will be a lot of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe significantly prior to going higher. I've been covering bitcoin for a long period of time now. Among the first research study reports I ever published was on bitcoin - jeff brown prediction. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my recommendation. However at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. white house. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date as of February 2021, however we could not independently validate this claim. Offered Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to select winning innovation stocks. He invested more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent viewpoint on the market. He's always on the hunt for new chances, and he shares much of his best choices in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively forecasted some of the greatest economic occasions of the past 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it best every time, however Jeff Brown's precise predictions have made him legions of dedicated fans. That says a lot about his ability. The Near Future Report is published by Brownstone Research study, a prominent monetary research publisher. Brownstone Research study uses several research study services with a broad range of expertises - first lady.
The company is also associated with Bonner & Partners, another well-respected research publisher - jeff bezos. On its website, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the finest investment research study has not been offered to specific financiers. It has been typically reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. exponential tech investor. The objective of Brownstone Research study is to make that kind of exclusive research study readily available to any investors aiming to gain an edge in the marketplaces. The objective is easy to provide unique and profitable financial investment research found no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise works as the firm's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you know even a bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown genetic sequencing stock. Everything he touches relies on gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown believes S.A.V. jeff brown market predictions. could be "the most significant pattern of the 2020s, and he's not alone. Inspect out these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying two innovative technologies: expert system and electric cars and trucks. Musk hopes the combination will assist him develop the very first fully-autonomous, self-driving cars and trucks ever. It's nothing except the automobile industry's Holy Grail. As you know, electric cars and self-driving car stocks have actually been huge this year, however the Wall Street device has actually been big on buzz without much tangible outcome. Despite a drastic boost in competition over the previous few years, Brown still thinks Musk has the best chance of putting all of it together.
tech could be the magic string that connects all of it together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transportation. Basically, this innovation would enable you to lease your vehicle as a self-governing, self-driving taxi when you're not using it. You simply get out of the cars and truck and press a button on an app that informs the vehicle to "join the fleet." Next thing you know, you're relaxing on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the earnings. It sounds outrageous, but it could be closed than you believe.